PAMAM dendrimer-coated iron oxide nanoparticles: Synthesis and characterization of different generations

Journal of Nanoparticle Research

Volumn 15, Issue 3, 2013, Pages

  Khodadust, Rouhollah ^a   Unsoy, Gozde ^a   Yalcın, Serap ^b   Gunduz, Gungor ^a   Gunduz, Ufuk ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b AHI EVRAN UNIVERSITY   (Turkey)

Author keywords

Cancer therapy; Dendrimer; Magnetic nanoparticle

Indexed keywords

COATINGS; DENDRIMERS; DISEASES; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; IRON OXIDES; LIGHT SCATTERING; METAL NANOPARTICLES; ONCOLOGY; PARTICLE SIZE ANALYSIS; PRECIPITATION (CHEMICAL); SIZE DISTRIBUTION; SUPERPARAMAGNETISM; SYNTHESIS (CHEMICAL); X RAY PHOTOELECTRON SPECTROSCOPY;

AMINOPROPYLTRIMETHOXYSILANE; CANCER THERAPY; CELLULAR INTERNALIZATION; MONODISPERSE SIZE DISTRIBUTION; POLYAMIDOAMINE DENDRIMERS; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SYNTHESIS AND CHARACTERIZATIONS; VIBRATING SAMPLE MAGNETOMETRY;

MAGNETIC NANOPARTICLES;

DENDRIMER; FUNCTIONAL GROUP; POLYAMIDOAMINE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TRIMETHOXYMETHYLSILANE;

ARTICLE; CYTOTOXICITY; DYNAMIC LIGHT SCATTERING; INFRARED SPECTROSCOPY; INTERNALIZATION; LIGHT SCATTERING; MAGNETISM; MAGNETOMETRY; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; VIBRATING SAMPLE MAGNETOMETRY; X RAY DIFFRACTION; X RAY PHOTOELECTRON SPECTROSCOPY;

EID: 84873701165     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-1488-6     Document Type: Article

References (53)

1. Acharya S, Dilnawaz F, Sahoo SK (2009) Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials 30:5737-5750
2. Arias JL, Gallardo V, Gómez-Lopera SA, Plaza RC, Delgado AV (2001) Synthesis and characterization of poly(ethyl-2-cyanosilane) nanoparticles with a magnetic core. J Control Release 13:309-321 (Pubitemid 33145482)
3. Bazylinski DA (1996) Controlled biomineralization of magnetic minerals by magnetotactic bacteria. Chem Geol 132:191-198
4. Boas U, Karlsson AJ, de Waal BF, Meijer EW (2001) Synthesis and properties of new thiourea-functionalized poly(propylene imine) dendrimers and their role as hosts for urea functionalized guests. J Org Chem 66(6):2136-2145 (Pubitemid 32867347)
5. Chou CM, Lien HL (2011) Dendrimer-conjugated magnetic nanoparticles for removal of zinc (II) from aqueous solutions. J Nanopart Res 13(5):2099-2107
6. Du X, Poltorak A, Wei Y, Beutler B (2000) Three novel mammalian toll like receptors: gene structure, expression, and evolution. Eur Cytokine Netw 11(3):362-371 (Pubitemid 32268893)
7. Duncan R, Izzo L (2005) Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 57:2215-2237 (Pubitemid 41759394)
8. Durmus Z, Kavas H, Toprak MS, Baykal A, AltInçekiç TG, Aslan A, Bozkurt A, Coşgun S (2009) l-lysine coated iron oxide nanoparticles: synthesis, structual and conductivity characterization. J Alloy Compd 484(1-2):371-376
9. Esfand R, Tomalia DA (2001) Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov Today 6:427-436 (Pubitemid 32328297)
10. Gao F, Pan BF, Zheng WM, Ao LM, Gu HC (2005) Study of streptavidin coated onto PAMAM dendrimer modified magnetite nanoparticles. J Magn Magn Mater 293:48-54 (Pubitemid 40625811)
11. Gupta AK, Wells S (2004) Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nano Biosci 3:66-73
12. Gurdag S, Khandare J, Stapels S, Matherly LH, Kannan RM (2006) Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines. Bioconjug Chem 17:275-283
13. Hansson GK, Edfeldt K (2005) Toll to be paid at the gateway to the vessel wall. Arterioscler Thromb Vasc Biol 25(6):1085-1087 (Pubitemid 40776589)
14. Hoa LTM, Dung TT, Danh TM, Duc NH, Chien DM (2009) Preparation and characterization of magnetic nanoparticles coated with polyethylene glycol. J Phys 187(1):012048. doi: 10.1088/1742-6596/187/1/012048
15. Hong S, Bielinska AU, Mecke A, Keszler B, Beals JL, Shi X, Balogh L, Orr BG, Baker JR Jr, Banaszak-Holl MM (2004) Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjug Chem 15:774-782 (Pubitemid 38981951)
16. Julian JM, Anderson DG, Brandau AH, McGinn JR, Millon AM (1991) In: Brezinski DR (ed) An infrared spectroscopy atlas for the coatings industry 1 federation of societies for coating technology, 4th edn. Blue Bell, Pennsylvania Vols I and II
17. Kukowska-Latallo JF, Candido KA, Cao Z, Nigavekar SS, Majoros IJ, Thomas TP, Balogh LP, Khan MK, Baker JR Jr (2005) Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res 65:5317-5324 (Pubitemid 40827344)
18. Lee CC, MacKay JA, Fréchet JM, Szoka FC (2005) Designing dendrimers for biological applications. Nat Biotechnol 23:1517-1526 (Pubitemid 41752929)
19. Lee CC, Gillies ER, Fox ME, Guillaudeu SJ, Fréchet JM, Dy EE, Szoka FC (2006) A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearingC-26 colon carcinomas. Proc Natl Acad Sci USA 103:16649-16654 (Pubitemid 44737307)
20. Liu WM, Xue YN, He WT, Zhuo RX, Huang SW (2011) Dendrimer modified magnetic iron oxide nanoparticle/DNA/PEI ternary complexes: a novel strategy for magnetofection. J Control Release 152:159-160
21. Mahmoudi M, Simchi A, Milani AS, Stroeve P (2009) Cell toxicity of superparamagnetic iron oxide nanoparticles. J Colloid Interface Sci 336(2):510-518
22. Majoros IJ, Keszler B, Woehler S, Bull T, Baker JR Jr (2003) Acetylation of poly(amidoamine) dendrimers. Macromolecules 36:5526-5529
23. Malik N, Evagorou EG, Duncan R (1999) Dendrimer-platinate: a novel approach to cancer chemotherapy. Anticancer Drugs 10:767-776 (Pubitemid 30015678)
24. Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R (2000) Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release 65:133-148 (Pubitemid 30122922)
25. Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46:6387-6392 (Pubitemid 17221789)
26. Matsunaga T, Sato R, Kamiya S, Tanaka T, Takeyama H (1999) Chemiluminescence enzyme immunoassay using protein A-bacterial magnetite complex. J Magn Magn Mater 194:126-131
27. Menjoge AR, Kannan RM, Tomalia DA (2010) Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today 15(5-6):171-185
28. Mornet S, Vekris A, Bonnet J, Duguet E, Grasset F, Choy JH, Portier J (2000) DNA-magnetite nanocomposite materials. Mater Lett 42:183-188 (Pubitemid 30535716)
29. Pan BF, Gao F, Gu HC (2005) Dendrimer modified magnetite nanoparticles for protein immobilization. J Colloid Interface Sci 284(1):1-6 (Pubitemid 40332441)
30. Pan B, Cui D, Sheng Y, Ozkan C, Gao F, He R, Li Q, Xu P, Huang T (2007) Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system. Cancer Res 67:8156-8163 (Pubitemid 47395151)
31. 4 inversespinal super paramagnetic nanoparticles. Mater Chem Phys 132:196-202
32. Reetz MT, Zonta A, Vijayakrishnan V, Schimossek K (1998) Entrapment of lipases in hydrophobic magnetite-containing sol-gel materials: magnetic separation of heterogeneous biocatalysts. J Mol Catal A 134:251-258 (Pubitemid 28463653)
33. Sato N, Kobayashi H, Hiraga A, Saga T, Togashi K, Konishi J, Brechbiel MW (2001) Pharmacokinetics and enhancement patterns of macromolecular MR contrastagents with various sizes of polyamidoamine dendrimer cores. Magn Reson Med 46:1169-1173 (Pubitemid 33104305)
34. Shimomura M, Abe T, Sato Y, Oshima K, Yamauchi T, Miyauchi S (2003) Sugar-binding property of magnetite particles modified with dihydroxyborylphenyl groups via graft polymerization of acrylic acid. Polymer 44:3877-3882 (Pubitemid 36713168)
35. Shukla R, Thomas TP, Peters J, Kotlyar A, Myc A, Baker JR Jr (2005) Tumor angiogenic vasculature targeting with PAMAM dendrimer RGD conjugates. Chem Commun (Camb) 14:5739-5741 (Pubitemid 43028741)
36. 3 nanoparticles by using a multifunctional polymeric linker. Small 3(8):1374-1378 (Pubitemid 47245530)
37. Singh P, Gupta U, Asthana A, Jain NK (2008) Folate and folate-PEG PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice. Bioconjug Chem 19(11):2239-2252
38. Slowing I, Trewyn BG, Lin VS (2006) Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J Am Chem Soc 128(46):14792-14793 (Pubitemid 44851603)
39. Stiriba SE, Frey H, Haag R (2002) Dendritic polymers in biomedical applications: from potential to clinical use indiagnostics and therapy. Angew Chem Int Ed Engl 41:1329-1334 (Pubitemid 34437413)
40. Svenson S (2009) Dendrimers as versatile platform in drug delivery applications. Eur J Pharm Biopharm 71:445-462
41. Svenson S, Tomalia DA (2005) Dendrimers in biomedical applications reflections on the field. Adv Drug Deliv Rev 57(15):2106-2129 (Pubitemid 41759389)
42. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335-376 (Pubitemid 37174535)
43. Tang Y, Li YB, Wang B, Lin RY, van Dongen M, Zurcher DM, Gu XY, Banaszak Holl MM, Liu G, Qi R (2012) Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers. Mol Pharm 9(6):1812-1821
44. Tanyolaç D, Özdural AR (2000) Preparation of low-cost magnetic nitrocellulose microbeads. React Funct Polym 45:235-242
45. Taylor JI, Hurst CD, Davies MJ, Sachsinger N, Bruce IJ (2000) Application of magnetite and silica-magnetite composites to the isolation of genomic DNA. J Chromatogr A 890:159-166 (Pubitemid 30619038)
46. Thomas TP, Patri AK, Myc A, Myaing MT, Ye JY, Norris TB, Baker JR Jr (2004) Invitro targeting of synthesized antibody conjugated dendrimer nanoparticles. Biomacromolecules 5:2269-2274 (Pubitemid 39585279)
47. Thomas TP, Majoros IJ, Kotlyar A, Kukowska-Latallo JF, Bielinska A, Myc A, Baker JR Jr (2005) Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J Med Chem 48(11):3729-3735 (Pubitemid 40776848)
48. Thorek DL, Tsourkas A (2008) Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 29(26):3583-3590
49. Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P (1985) A new class of polymers: starburst-dendritic macromolecules. Polym J 17:117-132
50. Unsoy G, YalcIn S, Khodadust R, Gunduz G, Gunduz U (2012) Synthesis optimization and characterization of chitosan-coated iron oxide nanoparticles produced for biomedical applications. J Nanopart Res 14:964
51. Uzun K, Çevik E, Şenel M, Sözeri H, Baykal A, AbasIyanIk FM, Toprak SM (2010) Covalent immobilization of invertase on PAMAM-dendrimer modified superparamagnetic iron oxide nanoparticles. J Nanopart Res 12(8):3057-3067
52. Wuang SC, Neoh KG, Kang ET, Pack DW, DE Leckband (2007) Synthesis and functionalization of polypyrrole-Fe3O4 nanoparticles for applications in biomedicine. J Mater Chem 17:3354-3362 (Pubitemid 47197869)
53. Zhuo RX, Du B, Lu ZR (1999) In vitro release of 5 fluorouracil with cyclic core dendritic polymer. J Control Release 57:249-257 (Pubitemid 29073440)